PREMATURE OVARIAN FAILURE 12
|
disease |
|
Disease or Syndrome
|
2
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
SPERMATOGENIC FAILURE 15
|
disease |
|
Disease or Syndrome
|
2
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Alcohol-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
54
|
180
|
0.310 |
None |
< 0.001 |
1 |
|
1999 |
2001 |
Carcinoma, Granular Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
116
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
L2 Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
53
|
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Carcinoma, Cribriform
|
disease |
Neoplasms
|
Neoplastic Process
|
117
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Cardiac Hypertrophy
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
88
|
11
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Adenocarcinoma, Oxyphilic
|
disease |
Neoplasms
|
Neoplastic Process
|
135
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Adenocarcinoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
123
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Adenocarcinoma, Tubular
|
disease |
Neoplasms
|
Neoplastic Process
|
133
|
3
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Micronuclei, Genotoxicant-Induced
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Cell Component
|
26
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Hepatoma, Novikoff
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
125
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Hepatoma, Morris
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
124
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Cardiomegaly
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Finding
|
267
|
11
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Drug toxicity
|
group |
Chemically-Induced Disorders
|
Injury or Poisoning
|
86
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Morbilliform Drug Reaction
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Drug Eruptions
|
group |
Skin and Connective Tissue Diseases; Immune System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
41
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Micronuclei, Chromosome-Defective
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Cell Component
|
26
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Liver Neoplasms, Experimental
|
phenotype |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
152
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
87
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Lymphoma, Diffuse
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
49
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Neoplasm Invasiveness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Pathologic Function
|
193
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Lymphoma, Intermediate-Grade
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
24
|
2
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Low Grade Lymphoma (neoplasm)
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
39
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Diffuse Mixed-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
21
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |